Capital Group Private Client Services’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $396K | Hold |
5,068
| – | – | ﹤0.01% | 262 |
|
|
2025
Q1 | $367K | Sell |
5,068
-101
| -2% | -$7.32K | ﹤0.01% | 260 |
|
|
2024
Q4 | $383K | Sell |
5,169
-209
| -4% | -$15.5K | ﹤0.01% | 254 |
|
|
2024
Q3 | $355K | Sell |
5,378
-879
| -14% | -$58K | ﹤0.01% | 250 |
|
|
2024
Q2 | $578K | Sell |
6,257
-161,282
| -96% | -$14.9M | 0.01% | 238 |
|
|
2024
Q1 | $16M | Sell |
167,539
-204,030
| -55% | -$19.5M | 0.16% | 125 |
|
|
2023
Q4 | $28.3M | Sell |
371,569
-404,392
| -52% | -$30.8M | 0.29% | 92 |
|
|
2023
Q3 | $53.8M | Buy |
775,961
+60,783
| +8% | +$4.21M | 0.65% | 53 |
|
|
2023
Q2 | $67.5M | Buy |
715,178
+12,692
| +2% | +$1.2M | 0.8% | 39 |
|
|
2023
Q1 | $58.1M | Buy |
702,486
+138,307
| +25% | +$11.4M | 0.72% | 44 |
|
|
2022
Q4 | $42.1M | Sell |
564,179
-83,066
| -13% | -$6.2M | 0.53% | 61 |
|
|
2022
Q3 | $53.5M | Buy |
647,245
+1,718
| +0.3% | +$142K | 0.75% | 41 |
|
|
2022
Q2 | $61.4M | Buy |
645,527
+143,333
| +29% | +$13.6M | 0.79% | 41 |
|
|
2022
Q1 | $59.1M | Buy |
502,194
+17,993
| +4% | +$2.12M | 0.65% | 50 |
|
|
2021
Q4 | $62.7M | Sell |
484,201
-3,801
| -0.8% | -$492K | 0.67% | 51 |
|
|
2021
Q3 | $55.2M | Buy |
+488,002
| New | +$55.2M | 0.64% | 58 |
|